| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 10% | +8.8% | $95,149,860 | +$23,507,430 | 8,729,345 | +33% | VIKING GLOBAL INVESTORS LP | 30 Jun 2025 |
| Nextech Crossover I GP S.a r.l. | 8.4% | $78,072,743 | 7,162,637 | Nextech Crossover I GP S.a. r.l. | 30 Jun 2025 | |||
| EcoR1 Capital, LLC | 6.9% | $73,336,464 | 6,728,116 | EcoR1 Capital, LLC | 29 Jul 2025 | |||
| Venrock Healthcare Capital Partners III, L.P. | 7.7% | +64% | $35,029,459 | +$18,130,241 | 6,596,885 | +107% | Venrock Healthcare Capital Partners III, L.P. | 08 Apr 2025 |
| BlackRock, Inc. | 5.6% | +35% | $44,773,610 | +$15,158,006 | 5,473,145 | +51% | BlackRock, Inc. | 31 Dec 2025 |
| SR ONE CAPITAL MANAGEMENT, LLC | 4.8% | -13% | $50,307,686 | 4,615,384 | 0% | SR One Capital Management, LLC | 12 Aug 2025 | |
| ALKEON CAPITAL MANAGEMENT LLC | 4.6% | $54,049,152 | 4,504,096 | Alkeon Capital Management LLC | 30 Sep 2025 | |||
| Point72 Asset Management, L.P. | 5.1% | $23,372,809 | 4,401,659 | Point72 Asset Management, L.P. | 29 May 2025 | |||
| COLUMN GROUP II, LP | 3.7% | $48,612,534 | 3,644,118 | Peter Svennilson | 30 Sep 2025 | |||
| FMR LLC | 3.5% | $13,967,797 | 2,467,809 | FMR LLC | 31 Dec 2024 | |||
| Frazier Life Sciences Public Fund, L.P. | 2% | $7,981,692 | 1,410,193 | James N. Topper | 31 Mar 2025 |
As of 31 Dec 2025, 98 institutional investors reported holding 53,055,828 shares of Oric Pharmaceuticals, Inc. - Common Stock (ORIC). This represents 54% of the company’s total 97,734,732 outstanding shares.
The largest institutional shareholders of Oric Pharmaceuticals, Inc. - Common Stock (ORIC) together control 50% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6% | 5,875,053 | +11% | 0% | $48,057,934 |
| Pfizer Inc | 5.5% | 5,376,344 | 0% | 19% | $43,978,494 |
| VANGUARD GROUP INC | 4.6% | 4,541,974 | -2.3% | 0% | $37,153,347 |
| SR One Capital Management, LP | 4.6% | 4,514,929 | 0% | 5.3% | $37,753,841 |
| STATE STREET CORP | 4.4% | 4,258,397 | +77% | 0% | $34,833,687 |
| Column Group LLC | 3.6% | 3,540,777 | 0% | 35% | $28,963,556 |
| Vivo Capital, LLC | 2.2% | 2,118,384 | -32% | 1.1% | $17,328,381 |
| First Turn Management, LLC | 2.1% | 2,010,307 | -6.9% | 1.9% | $16,444,311 |
| GOLDMAN SACHS GROUP INC | 2% | 1,939,285 | +114% | 0% | $15,863,351 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 1,750,694 | +7.4% | 0% | $14,323,065 |
| ROYCE & ASSOCIATES LP | 1.5% | 1,507,301 | +3.3% | 0.13% | $12,329,722 |
| DIMENSIONAL FUND ADVISORS LP | 1.3% | 1,227,230 | +55% | 0% | $10,037,866 |
| FRANKLIN RESOURCES INC | 1.2% | 1,212,547 | +2.6% | 0% | $9,918,634 |
| MORGAN STANLEY | 1.2% | 1,194,073 | +60% | 0% | $9,767,517 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.1% | 1,116,604 | -43% | 1.3% | $9,133,821 |
| Siren, L.L.C. | 1% | 1,007,575 | 0% | 0.25% | $8,241,964 |
| EVENTIDE ASSET MANAGEMENT, LLC | 0.97% | 952,371 | +0.09% | 0.12% | $7,790,303 |
| UBS Group AG | 0.75% | 734,858 | +117% | 0% | $6,011,138 |
| BARCLAYS PLC | 0.74% | 718,535 | +290% | 0% | $5,877,617 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.64% | 621,086 | +3% | 0% | $5,080,483 |
| NEXTBio Capital Management LP | 0.63% | 615,720 | 0% | 3% | $5,036,590 |
| RENAISSANCE TECHNOLOGIES LLC | 0.59% | 572,724 | +3850% | 0.01% | $4,684,882 |
| LORD, ABBETT & CO. LLC | 0.58% | 564,253 | 0.01% | $4,616,000 | |
| Blue Owl Capital Holdings LP | 0.53% | 515,000 | 0.32% | $4,212,700 | |
| JPMORGAN CHASE & CO | 0.42% | 414,786 | -66% | 0% | $3,392,950 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 53,055,828 | $434,809,578 | +$42,291,676 | $8.18 | 98 |
| 2025 Q3 | 106,492,104 | $1,277,897,818 | +$159,574,138 | $12.00 | 151 |
| 2025 Q2 | 93,349,298 | $947,499,065 | +$169,716,912 | $10.15 | 140 |
| 2025 Q1 | 79,209,337 | $442,004,992 | +$11,923,513 | $5.58 | 142 |
| 2024 Q4 | 75,794,185 | $611,682,254 | -$16,308,147 | $8.07 | 129 |
| 2024 Q3 | 69,823,199 | $715,076,569 | +$22,655,622 | $10.25 | 121 |
| 2024 Q2 | 67,575,796 | $477,762,911 | +$20,174,043 | $7.07 | 111 |
| 2024 Q1 | 63,945,767 | $879,254,046 | +$197,777,720 | $13.75 | 110 |
| 2023 Q4 | 50,638,764 | $465,880,631 | +$34,655,080 | $9.20 | 91 |
| 2023 Q3 | 48,053,106 | $290,723,321 | +$14,148,790 | $6.05 | 89 |
| 2023 Q2 | 45,537,877 | $353,374,535 | +$99,111,683 | $7.76 | 83 |
| 2023 Q1 | 33,075,099 | $188,527,951 | +$3,515,469 | $5.70 | 70 |
| 2022 Q4 | 32,430,291 | $192,141,081 | +$135,543 | $5.89 | 64 |
| 2022 Q3 | 32,701,288 | $104,643,704 | -$1,866,676 | $3.20 | 69 |
| 2022 Q2 | 32,837,327 | $147,127,000 | -$6,223,365 | $4.48 | 77 |
| 2022 Q1 | 33,856,070 | $180,750,917 | -$7,186,800 | $5.34 | 94 |
| 2021 Q4 | 34,857,324 | $512,119,938 | -$36,775,082 | $14.70 | 79 |
| 2021 Q3 | 31,534,174 | $659,370,855 | +$8,490,366 | $20.91 | 78 |
| 2021 Q2 | 36,145,561 | $639,409,737 | +$2,954,162 | $17.69 | 78 |
| 2021 Q1 | 35,685,685 | $874,284,848 | +$71,774,159 | $24.50 | 82 |
| 2020 Q4 | 32,607,853 | $1,103,814,951 | +$273,075,064 | $33.85 | 76 |
| 2020 Q3 | 22,151,969 | $552,859,000 | +$7,647,968 | $25.01 | 53 |
| 2020 Q2 | 21,388,813 | $718,339,063 | +$718,339,063 | $33.73 | 64 |